When I was 30 and giving birth, the migraine I had at the time hurt more than my contractions. Earlier, when I’d told my ...

The U.S. Food and Drug Administration on Tuesday approved Ajovy, an injection made by Israeli drugmaker Teva Pharma , to help ...

Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced that the first patients have been enrolled in two global Phase III clinical trials — MINT-E (NCT07018700 ...

More than 1.2 billion people worldwide suffer from migraine and other debilitating conditions that are under-studied and ...

The FDA has approved Ajovy for migraine prevention in children and teens, marking the first time a medication in its class is ...

Documents obtained by ProPublica offer a rare glimpse into discussions between the global drugmaker Sun Pharma and the FDA, ...

Teva offers strong value upside through disciplined execution and does not require growth surprise. Read more on TEVA stock ...

Teva Pharmaceutical's turnaround as branded drugs boost margins, generics stabilize, and biosimilars promise growth. See why ...

Chronic pain specialists told Newsweek that an integrative care model, like the one at SRAL, is considered the gold standard ...

The U.S. Food and Drug Administration has approved Tonmya (TNX-102 SL), a sublingual formulation of cyclobenzaprine HCl for ...

The awardees were celebrated for their life-bettering products at a banquet in Washington, DC, on Tuesday, Aug. 19 ...

In the world of fat activism, the “O-words” – overweight and obesity – are expressly verboten. That’s because advocates and “fat studies” scholars want to destigmatise and accommodate fatness – their ...